LT3119B - Pharmaceutical composition and process for the preparation thereof - Google Patents

Pharmaceutical composition and process for the preparation thereof Download PDF

Info

Publication number
LT3119B
LT3119B LTIP249A LTIP249A LT3119B LT 3119 B LT3119 B LT 3119B LT IP249 A LTIP249 A LT IP249A LT IP249 A LTIP249 A LT IP249A LT 3119 B LT3119 B LT 3119B
Authority
LT
Lithuania
Prior art keywords
inhibitor
phenyl
composition
composition according
deprenyl
Prior art date
Application number
LTIP249A
Other languages
English (en)
Lithuanian (lt)
Inventor
Kalman Magyar
Jozsef Gaal
Istvan Sziraki
Jozsef Lengyel
Anna Z Szabo
Katalin Marmarosi
Istvan Hermecz
Istvan Szatmari
Zoltan Torok
Peter Kormoczy
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of LTIP249A publication Critical patent/LTIP249A/xx
Publication of LT3119B publication Critical patent/LT3119B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LTIP249A 1991-12-20 1992-12-21 Pharmaceutical composition and process for the preparation thereof LT3119B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU914060A HUT63579A (en) 1991-12-20 1991-12-20 Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes

Publications (2)

Publication Number Publication Date
LTIP249A LTIP249A (en) 1994-07-15
LT3119B true LT3119B (en) 1994-12-27

Family

ID=10966728

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP249A LT3119B (en) 1991-12-20 1992-12-21 Pharmaceutical composition and process for the preparation thereof

Country Status (27)

Country Link
US (1) US5589513A (bg)
EP (1) EP0617615A1 (bg)
JP (1) JPH07502730A (bg)
KR (1) KR940703655A (bg)
AU (1) AU677170B2 (bg)
BG (1) BG98827A (bg)
BR (1) BR9206950A (bg)
CA (1) CA2125776A1 (bg)
CZ (1) CZ147494A3 (bg)
EC (1) ECSP930933A (bg)
EE (1) EE03015B1 (bg)
FI (1) FI942932A (bg)
HU (2) HUT63579A (bg)
IL (1) IL104150A (bg)
LT (1) LT3119B (bg)
LV (1) LV10386B (bg)
MY (1) MY111055A (bg)
NO (1) NO942303D0 (bg)
NZ (1) NZ246384A (bg)
PH (1) PH31073A (bg)
PL (1) PL172048B1 (bg)
RO (1) RO115785B1 (bg)
RU (1) RU2125448C1 (bg)
SI (1) SI9200404A (bg)
SK (1) SK74494A3 (bg)
WO (1) WO1993012775A1 (bg)
ZA (1) ZA929883B (bg)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
DE4432610C1 (de) * 1994-09-13 1996-02-01 Knoll Ag Verfahren zur Herstellung von Selegilin-Hydrochlorid
CA2212412A1 (en) 1995-02-10 1996-08-15 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
JP4499208B2 (ja) * 1998-10-29 2010-07-07 株式会社フジモト・コーポレーション 新規な光学活性アミノペンタン誘導体
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
HUP9902482A2 (hu) * 1999-07-22 2002-04-29 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. P-fluoro-selegilin alkalmazása neuroprotektív gyógyszerkészítmények előállítására
EP2053033A1 (en) * 2007-10-26 2009-04-29 Bayer Schering Pharma AG Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
DE102009045056A1 (de) * 2009-09-28 2011-03-31 Henkel Ag & Co. Kgaa Fleckenvorbehandlungsmittel
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1227447B (de) * 1962-03-30 1966-10-27 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Phenylisopropylaminen
HU193662B (en) * 1983-12-20 1987-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing synergetic pharmaceutical composition of antidepressive aktivity
HU207282B (en) * 1984-05-31 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing phenyl-alkyl-amine derivatives and pharmaceutical compositions containing them
EP0241809B1 (de) * 1986-04-16 1990-08-08 ASTA Pharma Aktiengesellschaft Synergistische Kombination von Amantadin und Selegilin
HU207280B (en) * 1986-09-25 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them
HU197510B (en) * 1986-12-19 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
CA2037178A1 (en) * 1990-02-28 1991-08-29 Albert Walter Brzeczko Deprenyl/l-dopa/carbidopa pharmaceutical composition
GB9011767D0 (en) * 1990-05-25 1990-07-18 Britannia Pharmaceuticals Ltd Pharmaceutical compositions
US5169868A (en) * 1991-03-01 1992-12-08 University Of Saskatchewan Aliphatic propargylamines as specific mao-b inhibitors
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
HU209605B (en) * 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
US5326770A (en) * 1992-07-17 1994-07-05 The Du Pont Merck Pharmaceutical Company Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
H. BLASCHKO: "Pharmacol", pages: 415
PIACKAR IR KT.: "Psychopharmacology", pages: 3087

Also Published As

Publication number Publication date
WO1993012775A1 (en) 1993-07-08
RU2125448C1 (ru) 1999-01-27
US5589513A (en) 1996-12-31
MY111055A (en) 1999-08-30
IL104150A (en) 1997-11-20
HU914060D0 (en) 1992-03-30
NO942303D0 (no) 1994-06-17
FI942932A0 (fi) 1994-06-17
CZ147494A3 (en) 1995-01-18
LV10386B (en) 1995-12-20
AU3265293A (en) 1993-07-28
PL172048B1 (pl) 1997-07-31
BR9206950A (pt) 1995-11-28
FI942932A (fi) 1994-06-17
LTIP249A (en) 1994-07-15
EE03015B1 (et) 1997-08-15
SK74494A3 (en) 1995-01-12
AU677170B2 (en) 1997-04-17
KR940703655A (ko) 1994-12-12
ZA929883B (en) 1994-05-16
RO115785B1 (ro) 2000-06-30
HU211478A9 (en) 1995-11-28
HUT63579A (en) 1993-09-28
JPH07502730A (ja) 1995-03-23
ECSP930933A (es) 1994-04-20
CA2125776A1 (en) 1993-07-08
PH31073A (en) 1998-02-05
SI9200404A (en) 1993-06-30
NZ246384A (en) 1996-02-27
BG98827A (bg) 1995-06-30
LV10386A (lv) 1995-02-20
NO942303L (bg) 1994-08-17
EP0617615A1 (en) 1994-10-05

Similar Documents

Publication Publication Date Title
LT3119B (en) Pharmaceutical composition and process for the preparation thereof
RU2140266C1 (ru) Фармацевтическая композиция с регулируемым выделением на основе одной или нескольких фармацевтически приемлемых солей гамма-гидроксимасляной кислоты и способ ее получения
US4556678A (en) Sustained release propranolol tablet
DK1919458T5 (en) Enteric-coated cysteamine, cystamine and derivatives thereof
CN100448439C (zh) 用于头痛、偏头痛、恶心和呕吐的药物组合物
US6191153B1 (en) Use of 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a pharmaceutical composition having an antidepressant activity
RU2006106464A (ru) Лекарственные формы с замедленным высвобождением зипразидона
NO339794B1 (no) Beskyttende middel for en retinal neuronal celle med et prostaglandin F2αderivat som aktiv bestanddel
JP3852621B2 (ja) 血管内皮細胞機能改善剤
EP1154762B1 (en) Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
TW200820995A (en) Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist
Woods et al. Exogenous tyrosine potentiates the methylphenidate-induced increase in extracellular dopamine in the nucleus accumbens: a microdialysis study
GR1009541B (el) Ποσιμα φαρμακευτικα διαλυματα που περιλαμβανουν μελατονινη
JPH02500596A (ja) 医薬組成物
ES2461196T3 (es) Procedimiento para estabilizar una preparación
US3360434A (en) Method for reducing blood pressure with phenylalanine derivatives
CZ281691B6 (cs) Farmaceutický prostředek proti vysokému krevnímu tlaku
DK169120B1 (da) Anvendelse af L-tryptophan og en perifer nedbrydningshæmmer for L-tryptophan til fremstilling af et smertestillende middel
RU2543637C2 (ru) Пролонгированная фармацевтическая композиция гипотензивного действия и способ ее изготовления
JPS6360727B2 (bg)
US5182285A (en) Cell-protective composition for preventing or treating of peptic ulcer
KR0184350B1 (ko) 오메프라졸 구강점막 부착 정제 조성물
US3642993A (en) Pharmaceutical composition containing 2-methyl - 5 - phenyl - 1 2-dihydro-3h-2-benzazepine for treatment of a condition associated with anxiety or tension
SK282448B6 (sk) Použitie derivátov cystínu
HU204997B (en) Process for producing carrier system suitable for ensuring controlled biological access to dihydropyridines, as well as new oral dosage form ensuring improved biological access

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 19981221